Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Loans - Gross (2022 - 2023)

Silo Pharma (SILO) has disclosed Loans - Gross for 2 consecutive years, with $69600.0 as the latest value for Q4 2023.

  • Quarterly Loans - Gross rose 5.44% to $69600.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $69600.0 through Dec 2023, up 5.44% year-over-year, with the annual reading at $69600.0 for FY2023, 5.44% up from the prior year.
  • Loans - Gross hit $69600.0 in Q4 2023 for Silo Pharma, up from $66010.0 in the prior quarter.
  • In the past five years, Loans - Gross ranged from a high of $69600.0 in Q4 2023 to a low of $66010.0 in Q4 2022.